阿司匹林降低PDE4D的调节,以通过NF-κB/p65途径抑制骨髓瘤恶性进展
Jinwu Wang1,2,3, Yan Zhang1,2,3, Zhuolun Li4
1Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, P.R. China.
Current medicinal chemistry
|January 16, 2026
概括
阿司匹林通过向NF-κB/p65/PDE4D轴来抑制骨髓瘤的进展. 这项研究确定PDE4D是关键的瘤基因,也是阿司匹林治疗骨髓瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 骨髓瘤是一种具有低生存率的侵袭性癌症.
- 阿司匹林显示出对抗骨质肉瘤的潜力,但其机制尚不清楚.
研究的目的:
- 为了阐明阿司匹林在骨髓瘤中的抗瘤机制.
- 确定阿司匹林的下游目标及其临床意义.
主要方法:
- RNA测序 (RNA-seq) 用于识别阿司匹林点.
- 在患者样本和数据库中分析PDE4D表达 (TARGET,GTEx).
- 在体外和体内测试以评估PDE4D功能和阿司匹林对NF-κB/p65/PDE4D轴的影响.
主要成果:
- 阿司匹林抑制了骨髓瘤细胞的增殖,迁移和入侵.
- 确定PDE4D是阿司匹林的关键标,在骨髓瘤中表达很高.
- 高PDE4D表达与患者的不良结果相关,并促进恶性瘤.
- NF-κB/p65直接调节PDE4D的表达.
结论:
- 阿司匹林通过抑制NF-κB/p65/PDE4D轴来产生抗瘤作用.
- PDE4D是骨髓瘤的一个瘤基因,也是潜在的治疗点.
- 这些发现为阿司匹林在骨髓瘤治疗中的使用提供了机制基础.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K

